NIH (Fauci’s NIAID agency) pockets $400 million dollars in “royalties” due to the Bayh/Doyle Act (2005)


NIH’s National Institute of Allergy and Infectious Disease (NIAID )  FAUCI’S AGENCY is to receive a “catch-up” non-refundable royalty in the amount of $400 million from Moderna for the use of its molecular technique. The molecular technique aims to stabilize the SARS-COV2 spike protein in order to create a strong immune response in vaccine recipients. The spike protein technology is jointly owned by the NIH and Dartmouth University’s Geisel School of Medicine, and both are named in the contract along with Moderna.5 6

The collaboration between NIH and Moderna in the development of Spikevax is another example of the lucrative public-private business partnership between the U.S. government and pharmaceutical companies.18 19 20

VLA COMMENT: Not mentioned in the article is that this collusion is a result of the UNINTENDED CONSEQUENCES OF Bayh-Dole Act of Congress…

At the time, the gospel of the U.S. government, or at least of the longtime Democratic majority in Congress, was that if the government paid for it, the taxpayers owned it. That was the thinking that drove some of the nation’s proudest achievements–the splitting of the atom, the development of antibiotics, the moon shot, and the nuclear Navy. Bayh sought to turn that policy on its head, essentially giving away all this taxpayer property for free–and, some worried, creating potentially thousands of new private monopolies in the process.



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.